参考文献/References:
[1] 郑荣寿,张思维,吴良有,等.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12.
ZHENG Rongshou,ZHANG Siwei,WU Liangyou,et al.Report of incidenceand mortality from China cancer registries in 2008[J].China Cancer,2012,21(1):1-12.
[2] 曾红梅,郑荣寿,张思维,等.1989～2008年中国恶性肿瘤死亡趋势分析[J].中华肿瘤杂志,2012,34(7):525-531.
ZENG Hongmei,ZHENG Rongshou,ZHANG Siwei,et al.Trend analysis of cancer mortality in China between 1989 and2008[J].Chinese Journal of Oncology,2012,34(7):525-531.
[3] CHEN Wenqing.Cancer statistics:Updated cancer burden in China[J].Chin J Cancer Res,2015,27(1):1.
[4] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2019[J].CA CancerJ Clin,2019,69(1):7-34.
[5] 张善弟,荆成宝,禹梅.血清CEA,CA125和HE4联合检测对卵巢癌的诊断价值 [J].现代检验医学杂志,2018,33(6):122-124,131.
ZHANG Shandi,JING Chengbao,YU Mei.Clinial value of combined detection of serum CEA,CA125,and HE4 in the diagnosis of ovarian cancer[J].Journal of Modern Laboratory Medicine,2018,33(6):122-124,131.
[6] 马同敏,赵志强.血清CA125,STPI和IGF-1联合检测对卵巢癌的早期诊断价值研究[J].现代检验医学杂志,2018,33(6):50-54,58.
MA Tongmin,ZHAO Zhiqiang.Clincal value of combined detection of serum CA125,STIP1 and IGF-I level in early diagnosis of ovarian cancer[J].Journal of Modern Laboratory Medicine,218,33(6):50-54,58.
[7] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[8] 徐金良,杜丹丹,翟志敏,等.卵巢良恶性肿瘤患者血液NIR,IMR,RDW,PLR四项参数的变化及其临床意义[J].现代检验医学杂志,2018,33(2):16-18,22.
XU Jinliang,DU Dandan,ZHAI Zhimin,et al.Changes and clinical significance of four parameters of NLR,LMR,RDW and PLR in patients with benign and malignant ovarian tumors[J].Journal of Modern Laboratory Medicine,2018,33(2):16-18,22.
[9] 曹雪娇,董丽娜,谭文华,等.NDRG4在卵巢癌中的表达[J].哈尔滨医科大学学报,2017,51(5):434-437.
CAO Xuejiao,DONG Lina,TAN Wenhua,et al.Expression of NDRG4 in ovarian cancer[J].Journal of Harbin Medical University,2017,51(5):434-437.
[10] CHEN Wanqing,SUN Kexin,ZHENG Rongshou,et al.Cancer incidenceand mortality in China,2014[J].Chin J Cancer Res,2018,30(1):1-12.
[11] CHEN Wanqing, ZHENG Rongshou, ZHANG Siwei,et al.Cancer incidence andmortality in China in 2013:an analysis based on urbanization level[J].ChinJ Cancer Res,2017,29(1):1-10.
[12] DESANTIS C E,LIN C C,MARIOTTO A B,et al.Cancer treatment and survivorship statistics,2014[J].CA Cancer J Clin,2014,64(4):252-271.
[13] FERLAY J,COLOMBET M,SOERJOMATARAM I,et al.Cancer incidence and mortality patterns in Europe:Estimates for 40 countries and 25 major cancers in 2018[J].Eur J Cancer,2018,103:358-387.
[14] KASSEBAUM N J,BERTOZZI-VILLA A,COGGESHALL M S,et al.Global,regional,and national levels and causes of maternal mortality during 1990-2013:A systematic analysis for the global burden of disease study 2013[J].Lancet,2014,384(9947):980-1004.
[15] SMITH R A,MANASSARAM-BAPTISTE D,BR-OOKS D,et al.Cancer screening in the united states,2015:A review of current American Cancer Society guidelines and current issues in cancer screening[J].CA Cancer J Clin,2015,65(1):30-54.
[16] ZENG Hongmei,ZHENG Rongshou,GUO Yuming,et al.Cancer survival in China,2003～2005:a population-based study[J].Int J Cancer,2015,136(8):1921-1930.
[17] 赵慧霞,李秋文,董伟伟,等.NDRG4基因甲基化检测在结直肠癌早期诊断中的应用研究[J].中国医药导报,2012,9(13):29-31.
ZHAO Huixia,LI Qiuwen,DONG Weiwei,et al.Study of early diagnosis of colorectal cancer by analysis of NDRG4 gene methylation[J].China Medical Herald,2012,9(13):29-31.
[18] 严志进,刘云龙,邹秉杰,等.粪便中大肠癌特异性NDRG4基因甲基化水平的超高灵敏定量检测法[J].医学研究生学报,2016,29(10):1031-1035.
YAN Zhijin,LIU Yunlong,ZOU Bingjie,et al.Ultra-sensitive quantification of the colorectal cancer-specific NDRG4 gene methylation levels in stool[J].J Med Postgra,2016,29(10):1031-1035.
[19] 商远方,朱耀明,朱晨宇.NDRG4基因的表达调控及生物学效应研究进展[J].生命科学,2012,24(7):691-695.
SHANG Yuanfang,ZHU Yiaoming,ZHU Chenyu.Research advancement of expression regulation and biological effects of NDRG4 gene[J].Chinese Bulletin of Life Sciences,2012,24(7):691-695.
[20] 罗会芳,张勇.NDRG4在宫颈癌细胞中的表达及其对增殖的影响[J].实用医学杂志,2016,32(22):3673-3676.
相似文献/References:
[1]蔡加炉,王 成,汪俊军.循环微小核糖核酸与2型糖尿病的关系[J].现代检验医学杂志,2015,30(03):5.[doi:10.3969/j.issn.1671-7414.2015.03.002]
CAI Jia-lu,WANG Cheng,WANG Jun-jun.Relationship between Circulating miRNA and Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2015,30(05):5.[doi:10.3969/j.issn.1671-7414.2015.03.002]
[2]唐海霞,王 成,路美玲,等.肾透明细胞癌患者血清miR-193a-3p水平增加及早期诊断价值[J].现代检验医学杂志,2015,30(03):43.[doi:10.3969/j.issn.1671-7414.2015.03.012]
TANG Hai-xia,WANG Cheng,LU Mei-ling,et al.Elevated Serum miR-193a-3p Level in Renal Clear Cell
Carcinoma and Its Early Clinical Value[J].Journal of Modern Laboratory Medicine,2015,30(05):43.[doi:10.3969/j.issn.1671-7414.2015.03.012]
[3]黄金文,李如凯,高 婧,等.孕妇血清半胱氨酸蛋白酶抑制剂C参考范围的研究[J].现代检验医学杂志,2016,31(04):133.[doi:10.3969/j.issn.1671-7414.2016.04.039]
HUANG Jin-wen,LI Ru-kai,GAO Jing,et al.Study on the Reference Interval of Serum Cystatin C of Pregnant Women[J].Journal of Modern Laboratory Medicine,2016,31(05):133.[doi:10.3969/j.issn.1671-7414.2016.04.039]
[4]万淑君,王 成,王 静,等.2型糖尿病微血管并发症患者血清miR-16,miR-126和miR-221水平检测及临床意义[J].现代检验医学杂志,2016,31(05):9.[doi:10.3969/j.issn.1671-7414.2016.05.003]
WAN Shu-jun,WANG Cheng,WANG Jing,et al.Study on Serum Levels of miR-16,miR-126 and miR-221
and Their Clinical Significance in Type 2 Diabetes Patients
with or Without Microvascular Complications[J].Journal of Modern Laboratory Medicine,2016,31(05):9.[doi:10.3969/j.issn.1671-7414.2016.05.003]
[5]朱卫华,刘继斌,林兰.胃癌相关甲基化分型与幽门螺杆菌感染的探讨[J].现代检验医学杂志,2016,31(06):55.[doi:10.3969/j.issn.1671-7414.2016.06.015]
ZHU Wei-hua,LIU Ji-bin,LIN Lan.Relationship between the CpG Island Methylator Phenotype
and Helicobacter Pylori Infection Associated with Gastric Cancer[J].Journal of Modern Laboratory Medicine,2016,31(05):55.[doi:10.3969/j.issn.1671-7414.2016.06.015]
[6]李兵,傅尧,符义富,等.IL-17F在口腔鳞状细胞癌患者血清中的表达及意义[J].现代检验医学杂志,2016,31(06):77.[doi:10.3969/j.issn.1671-7414.2016.06.021]
LI Bing,FU Yao,FU Yi-fu,et al.Expression of Interleukin 17F in Serum of Oral Squamous Cell
Carcinoma Patients and Its Clinic Significance[J].Journal of Modern Laboratory Medicine,2016,31(05):77.[doi:10.3969/j.issn.1671-7414.2016.06.021]
[7]卜晓敏,宋佳希,樊春荔,等.颅脑损伤患者血清αⅡ血影蛋白裂解产物(SBDPs)水平检测的临床意义[J].现代检验医学杂志,2017,32(01):9.[doi:10.3969/j.issn.1671-7414.2017.01.003]
BU Xiao-min,SONG Jia-xi,FAN Chun-li,et al.Study on Serum Levels of SBDPs and Their Clinical Significance
in Patients with Traumatic Brain Injury[J].Journal of Modern Laboratory Medicine,2017,32(05):9.[doi:10.3969/j.issn.1671-7414.2017.01.003]
[8]李 兵a,傅 尧a,符义富a,等.口腔鳞状细胞癌患者血清中CCL2和VEGF表达的初步研究[J].现代检验医学杂志,2017,32(04):64.[doi:10.3969/j.issn.1671-7414.2017.04.018]
LI Binga,FU Yaoa,FU Yi-fua,et al.Preliminary Study on the Expression of CCL2 and VEGF
in Serum of Patients with Oral Squamous Cell Carcinoma[J].Journal of Modern Laboratory Medicine,2017,32(05):64.[doi:10.3969/j.issn.1671-7414.2017.04.018]
[9]黄钰君,伍绍国,丘媛媛,等.广州地区正常儿童血清叶酸参考区间调查[J].现代检验医学杂志,2017,32(04):125.[doi:10.3969/j.issn.1671-7414.2017.04.036]
HUANG Yu-jun,WU Shao-guo,QIU Yuan-yuan,et al.Investigation of the Normal Reference Range
for Serum Folate of Healthy Children in Guangzhou Region[J].Journal of Modern Laboratory Medicine,2017,32(05):125.[doi:10.3969/j.issn.1671-7414.2017.04.036]
[10]武 琪a,陈 亮b,张宝华c.帕金森病患者血清和脑脊液褪黑素水平变化及其临床意义[J].现代检验医学杂志,2017,32(05):90.[doi:10.3969/j.issn.1671-7414.2017.05.017]
WU Qia,CHEN Liangb,ZHANG Bao-huac.Changes and Clinical Significance of Melatonin in Blood
and Cerebrospinal Fluid of Patients with Parkinson's Disease[J].Journal of Modern Laboratory Medicine,2017,32(05):90.[doi:10.3969/j.issn.1671-7414.2017.05.017]